NOGNOG
US • —
$18.15
P/E
50.80
PEG
—
FCF Yield
—
Rev Growth YoY
-22.7% YoY
Gross Margin
66.8%
Health Score
4/10
D/E Ratio
1.13
Confidence
LOW
Business Snapshot
This company is an independent energy producer focused on oil and natural gas assets in the United States, primarily generating revenue through the sale of crude oil, natural gas, and natural gas liquids. It operates as a mid-tier player in the upstream energy sector, competing with larger integrated producers and smaller independent operators. The company’s defining characteristic is its consistent earnings beat record, having surpassed analyst estimates in all four of the most recent quarters, suggesting disciplined operational execution. The financial scale of the company is challenging to assess precisely as TTM revenue is not provided in the data payload.
Financial Health
The company’s financial health presents a mixed picture with a significant profitability problem. Gross margin stands at a strong 66.8%, but the net margin is deeply negative at -33.2%, indicating that high operating or financing costs are erasing any gross profit and resulting in a net loss...
Risk Assessment
- VALUATION — The trailing P/E of 50.8x is significantly elevated versus the sector average of 22x, implying a high earnings premium despite declining revenue.
- EARNINGS QUALITY — The net margin is deeply negative at -33.2%, indicating the company is unprofitable on a trailing twelve-month basis, which undermines earnings quality.
- REVENUE DECELERATION — Revenue has declined by 22.7% year-over-year, a clear sign of business contraction that makes current profitability elusive.
- PROFITABILITY — Return on equity is negative at -29.1%, showing the company is destroying shareholder value rather than generating a return.
- FCF / CASH BURN — Free cash flow is not available in the data, but the negative net margin and declining revenue strongly suggest the company is likely consuming cash, which could pressure the balance sheet.
- TECHNICALS — RSI, MACD, and moving average data are unavailable for this period; momentum cannot be independently confirmed....
The company’s financial health presents a mixed picture with a significant profitability problem. Gross margin stands at a strong 66.8%, but the net margin is deeply negative at -33.2%, indicating that high operating or financing costs are erasing any gross profit and resulting in a net loss. The balance sheet is moderately leveraged, with a debt-to-equity ratio of 1.13x, and liquidity appears adequate with a current ratio of 1.09x, suggesting near-term obligations are currently covered. A major concern is the return on equity, which is a negative -29.1%, showing the company is not generating a profit on shareholder equity. Free cash flow figures are not available, making it impossible to assess the company’s ability to internally fund operations or service its debt, which represents a significant information gap for investors.
- VALUATION — The trailing P/E of 50.8x is significantly elevated versus the sector average of 22x, implying a high earnings premium despite declining revenue. - EARNINGS QUALITY — The net margin is deeply negative at -33.2%, indicating the company is unprofitable on a trailing twelve-month basis, which undermines earnings quality. - REVENUE DECELERATION — Revenue has declined by 22.7% year-over-year, a clear sign of business contraction that makes current profitability elusive. - PROFITABILITY — Return on equity is negative at -29.1%, showing the company is destroying shareholder value rather than generating a return. - FCF / CASH BURN — Free cash flow is not available in the data, but the negative net margin and declining revenue strongly suggest the company is likely consuming cash, which could pressure the balance sheet. - TECHNICALS — RSI, MACD, and moving average data are unavailable for this period; momentum cannot be independently confirmed.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives